Records containing: Influenza

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-01-03
  Phase 1 Inpatient Study of the Safety and Immunogenicity of One Dose of Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/Chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca), a Live Attenuated Virus Vaccine Candidate for Prevention of Avian Influenza H7N3 Infection in the Event of a Pandemic
• CLINICAL_TRIALS study record update · 2012-12-28
  ClinicalTrials.gov study NCT01356342
• CLINICAL_TRIALS study record update · 2012-12-24
  Immunogenicity, Reactogenicity and Safety of GSK Biologicals' Quadrivalent Influenza Vaccine FLU Q-QIV (GSK2282512A) When Administered Intramuscularly to Adults 18 Years of Age and Older
• CLINICAL_TRIALS study record update · 2012-12-19
  Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects
• CLINICAL_TRIALS study record update · 2012-12-17
  Immunogenicity of Two Dosages of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine Administered in Healthy Adult Subjects Aged 18 to 49 Years
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-12-17
  Effect of Influenza Vaccine Against Mismatched Strains: Systematic Review
• CLINICAL_TRIALS study record update · 2012-11-29
  A Phase I Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults
• CLINICAL_TRIALS study record update · 2012-11-29
  A Phase I Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine
• CLINICAL_TRIALS study record update · 2012-11-27
  Cell-mediated Immunity Study of H1N1 Influenza A Vaccine With Trivalent Inactivated Influenza Vaccine in Healthy Adults
• CLINICAL_TRIALS study record update · 2012-11-26
  A Two-Part Placebo-Controlled Evaluation of the Safety and Immunogenicity of an A/Indonesia/5/05 Recombinant Hemagglutinin Influenza H5N1 Vaccine With and Without Glucopyranosyl Lipid A (GLA-SE) in Healthy Adults 18-49
• CLINICAL_TRIALS study record update · 2012-11-19
  Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections
• CLINICAL_TRIALS study record update · 2012-11-02
  A Randomised Double-blind, Placebo-controlled, Phase 1b Trial to Evaluate the Safety, Tolerability and Protective Efficacy of the Influenza Vaccine Candidate, FLU-v, in an Influenza Challenge Model
• CLINICAL_TRIALS study record update · 2012-11-01
  A Phase 2a, Double-Blind, Placebo-Controlled Study TCN 032 (Human Monoclonal Antibody Directed Against the M2 Protein of Influenza A Virus) in Subjects Challenged With H3N2 Influenza A Virus
• CLINICAL_TRIALS study record update · 2012-10-12
  Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 15 ugHA/Strain/0.5mL) in Adult and Elderly Subjects
• CLINICAL_TRIALS study record update · 2012-10-08
  An Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation, Phase IV Trial
• CLINICAL_TRIALS study record update · 2012-10-03
  A Phase II, Multicenter, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults Aged 18 Years and Older
• CLINICAL_TRIALS study record update · 2012-10-02
  Evaluation of Safety and Immunogenicity Among Different Age-groups Receiving Different Split Influenza Vaccines
• CLINICAL_TRIALS study record update · 2012-10-01
  A Case-Control Study to Evaluate the Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine in the Elderly Aged ≥65 Years.
• CLINICAL_TRIALS study record update · 2012-09-27
  Evaluating Modes of Influenza Transmission Using a Human Challenge/Exposure Model
• CLINICAL_TRIALS study record update · 2012-09-19
  A Phase II, Randomized, Placebo-controlled, Observer-blind, Multi Center Study on the Safety and Immunogenicity of Novartis Tetravalent Influenza Vaccine (Containing Both Interpandemic Strains and H5N1) in Adults Aged 18 Years and Above
• CLINICAL_TRIALS study record update · 2012-09-12
  A Double-blind, Randomized, Stratified and Controlled Clinical Trial With Split-virion, Adjuvanted and Non-adjuvanted Influenza A/H1N1 Vaccines in Healthy Adults, Elders, Adolescents and Children
• CLINICAL_TRIALS study record update · 2012-09-10
  Burden of Influenza in the United Kingdom, 1996-2008
• CLINICAL_TRIALS study record update · 2012-09-06
  A Double - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion)(0.25ml Formulation for Pediatric Use)
• CLINICAL_TRIALS study record update · 2012-09-06
  A Single - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion) (0.5ml Formulation)
• CLINICAL_TRIALS study record update · 2012-09-05
  Reactogenicity and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK576389A in Elderly Adults (≥66 Years) Previously Vaccinated With the Same Candidate Vaccine. Fluarix™ Will be Used as Reference